Prof David Siegel talks to ecancer at the International Myeloma Workshop 2019 about autologous stem cell transplant in multiple myeloma.

He recounts some of the discussion that occurred at this years conference between panelists and the audience debating whether autologous stem cell transplant still has a place in multiple myeloma treatment.

Prof Siegel gives some of the reasons as to why the consensus was generally 'yes'.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

свернуть